Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Colleague Insights
Grand Rounds
Conferences
Video Expert Opinion
Living Resources
Sign in
Join now
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
Peter Libby MD
Peter Libby MD Advisory Board
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
See All Experts
story of the week
Published in Cardiology and
2 other channels

Journal Scan / Research · October 29, 2020

Effect of Empagliflozin on the Clinical Stability in HFrEF

Circulation

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Christopher Cannon MD

Circulation
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial
Circulation 2020 Oct 21;[EPub Ahead of Print], M Packer, SD Anker, J Butler, GS Filippatos, JP Ferreira, S Pocock, PE Carson, IS Anand, W Doehner, M Haass, M Komajda, AB Miller, S Pehrson, JR Teerlink, M Brueckmann, W Jamal, C Zeller, S Schnaidt, F Zannad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated